Cancer BiologybioRxivPreprint
Reduced CREB3L2 expression is associated with resistance to sorafenib and poor prognosis in ER-positive breast cancer
Sean Mullarkey, Vahid Arabkari, Muhammad Mosaraf Hossain…·Ananya Gupta
The paper identifies CREB3L2 expression as a biomarker for sorafenib response and poor prognosis in ER-positive breast cancer.
DOI 10.1101/078949